Local Institution - 0005 — Boston, Massachusetts

Local Institution - 0005 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 0005 has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma.

Sponsors: Juno Therapeutics, a Subsidiary of Celgene, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0005?

Local Institution - 0005 has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0005 conducted?

Local Institution - 0005 has 6 clinical trials on record, with 2 currently active. Their work covers Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma.

Is Local Institution - 0005 accredited by Crixeo Health?

Yes — Local Institution - 0005 holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Local Institution - 0005?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.